FRANKFURT (dpa-AFX) - Lonza Group (LZAGF.PK), a Swiss healthcare firm, on Friday posted a surge in profit for the first half, reflecting increased revenues and a decline in operating expenses.
For the six-month period to June 30, the company registered a profit of CHF 494 million or CHF 6.67 per share, compared with CHF 321 million or CHF 3.50 per share, reported a year ago.
Profit before income taxes was at CHF 594 million, a jump from CHF 296 million from last year.
The Basel-headquartered drug maker's result from operating activities or EBIT surged to CHF 645 million, from CHF 317 million, reported for first six-month period of 2021.
Operating expenses were at CHF 551 million, less than CHF726 million recorded a year ago.
Lonza's first half sales were registered at CHF 2.982 billion, compared with CHF 2.542 billion during the corresponding period of previous year.
Copyright(c) 2022 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2022 AFX News
